FDA experts back Merck's application to extend the use of Gardasil to males In twin votes likely to add considerable force to U.S. marketing efforts for HPV vaccines, an FDA expert panel has voted to back GlaxoSmithKline's long delayed application to market its HPV vaccine … [Read more...] about Cervarix On Track for FDA Approval, Garasil to Have Expanded Use
Cervarix
Glaxo Claims Cervarix More Effective Than Gardasil
Glaxo says its HPV shot outperforms Merck's When GlaxoSmithKline announced that it would unveil head-to-head trial data on its HPV vaccine long after the fact and at a lesser-known meeting, folks speculated that the drugmaker might be embarrassed of the trial's outcome. Not … [Read more...] about Glaxo Claims Cervarix More Effective Than Gardasil
GlaxoSmithKline Cervarix Press Release
New data for GlaxoSmithKline's vaccine, Cervarix, presented at IPV Conference Issued: Friday 8 May 2009, London, UK & Malmö, Sweden Key results from three important studies of the cervical cancer vaccine, Cervarix®, will be available as of today at the 25th International … [Read more...] about GlaxoSmithKline Cervarix Press Release
Can Glaxo learn from Merck
Will they absorb lessons learned from Merck’s mistakes? As Glaxo is forced to wait for FDA’s approval for its own HPV vaccine, Cervarix, will the company use its time on the sidelines to absorb lessons learned from Merck’s missteps? There is a building backlash against Merck’s … [Read more...] about Can Glaxo learn from Merck
Glaxo wins European contract for Cervarix
GlaxoSmithKline has won another European contract for the cervical cancer vaccine Cervarix. The Dutch government selected Cervarix for a new program to vaccinate all girls aged 12 with a catch-up program for girls aged 13 to 16 in the second half of 2009. In the first year some … [Read more...] about Glaxo wins European contract for Cervarix